Status:

COMPLETED

Effect on Adrenal Function of Budesonide Versus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD)

Lead Sponsor:

Hull University Teaching Hospitals NHS Trust

Conditions:

Chronic Obstructive Pulmonary Disease

Eligibility:

All Genders

18-85 years

Phase:

PHASE4

Brief Summary

National Institute for Clinical Excellence (NICE) guidelines recommend high dose inhaled steroids for patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD, a common chronic dis...

Detailed Description

Background COPD is a very common disease which is chronic and progressive. Current NICE guidelines recommend the use of inhaled steroid in relatively high dose in patients with moderate to severe dise...

Eligibility Criteria

Inclusion

  • Patients with a diagnosis of COPD.
  • Criteria for treatment with inhaled steroids met as per NICE guidelines.
  • Patients on treatment with either Symbicort® or Seretide® at the time of recruitment (on treatment dose as per NICE guidelines).
  • Recruited patients are able to understand and co-operate with the study conduct and are willing to give written consent.

Exclusion

  • Patients with any concomitant disease which may interfere with the study procedure or evaluation.(self explanatory)
  • A recent exacerbation of COPD within the last 8 weeks.( will interfere with assessment )
  • Use of oral steroids within the last 2 months.(will interfere with assessment)
  • Use of ocular, intra-articular, rectal or other steroids during 4 weeks prior to inclusion.(will interfere with assessment)
  • Participation in any other study (use of investigational product) within 4 weeks prior to inclusion.(potential to interfere with assessment)
  • Alcohol or drug abuse.(will interfere with assessment)
  • Inability to follow study procedures.(self explanatory)

Key Trial Info

Start Date :

October 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2010

Estimated Enrollment :

22 Patients enrolled

Trial Details

Trial ID

NCT01186653

Start Date

October 1 2007

End Date

May 1 2010

Last Update

September 6 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Respiratory Medicine, Castgle Hill Hospital

Cottingham, East Yorkshire, United Kingdom, HU16 5JQ